leisure time -WSS

leisure time

author：knowledge 2025-09-28 02:28:00 - browse：6

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medical device lobby: We're tired of waiting on Medicare coverage

focus

WSS

RaDonda Vaught to speak at CommonSpirit event on patient safety

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

An inside look at PIPEs, biotech's buzzy new financing tool

Flu vaccine offering decent levels of protection this winter, new data show

Clinical trials giant ICON acquires HumanFirst

hotspot

leisure time

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Pfizer highlights cancer drugs it thinks could reignite investor interest

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Covid isolation guidance eased by the CDC

As demand for Covid shots wanes, Moderna seeks its next success

Biotech companies concerned about China biosecurity crackdown

What does generative AI mean for health care? We asked experts

AstraZeneca loses challenge to Medicare drug price negotiation

Heart attack and stroke risk calculators need revising

Flu vaccine offering decent levels of protection this winter, new data show

Wikipedia

Clinical trials giant ICON acquires HumanFirst

Obesity now affects over 1 billion people worldwide, study finds

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Kenai launches with $82 million for Parkinson’s stem cell therapy

AstraZeneca loses challenge to Medicare drug price negotiation

Obesity now affects over 1 billion people worldwide, study finds

leisure time

hotspot

focus

hotspot